FEF Values in Patients with Normal Lung Function Can Predict the Development of Chronic Obstructive Pulmonary Disease
Overview
Authors
Affiliations
Purpose: The forced mid-expiratory flow (FEF) value is a potentially sensitive marker of obstructive peripheral airflow. We aimed to assess whether FEF can be an early predictor of chronic obstructive pulmonary disease (COPD).
Patients And Methods: Between July 1, 2007 and June 31, 2009, we identified 3624 patients who underwent a pulmonary function test (PFT) in Gangnam Severance Hospital. We selected 307 patients aged over 40 years without COPD who had normal PFT results at baseline and who had follow-up PFT records more than 1 year later. A FEF z-score less than -0.8435 was considered low. We defined COPD as a forced expiratory volume in one second/forced vital capacity value of less than 0.7 before July 31, 2019.
Results: Among 307 patients, 91 (29.6%) had low FEF at baseline. After 10 years, the incidence rate of COPD in the low FEF group was significantly higher than that in the normal FEF group (41.8% vs 7.4%; <0.001). The Cox proportional hazard model showed that age (hazard ratio [HR] 1.09; -value<0.001), smoking status (occasional smoker HR, 4.59; -value<0.001 and long-term smoker HR, 2.18; -value=0.023), and low FEF (HR, 3.31; -value<0.001) were predictive factors for the development of COPD.
Conclusion: The FEF value in patients with normal lung function is a useful predictor for the development of COPD. We should carefully monitor patients who present with low FEF values, even if they have normal lung function.
Almeshari M, Alobaidi N, Stockley J, Stockley R, Nagakumar P, Sutton B J Asthma Allergy. 2025; 18:377-389.
PMID: 40066295 PMC: 11892509. DOI: 10.2147/JAA.S489893.
Lam A, Alhajri S, Potts J, Harrabi I, Anand M, Janson C ERJ Open Res. 2025; 11(2).
PMID: 40040898 PMC: 11873882. DOI: 10.1183/23120541.00624-2024.
Liu W, Feng Q, Yuan X, Lu C, Wang S, Yuan Y Front Med (Lausanne). 2025; 11():1512658.
PMID: 39830383 PMC: 11738905. DOI: 10.3389/fmed.2024.1512658.
Septoplasty-mediated improvements in nasal patency and pulmonary function: A prospective study.
Sousa F, Correia J, Carvalho Almeida J, Raquel Azevedo S, Ferreira M, Magalhaes M Laryngoscope Investig Otolaryngol. 2025; 10(1):e70065.
PMID: 39780865 PMC: 11705537. DOI: 10.1002/lio2.70065.
Kilincer M, Gursoy E BMC Public Health. 2025; 25(1):16.
PMID: 39748373 PMC: 11697805. DOI: 10.1186/s12889-024-21246-6.